Free shipping on all orders over $ 500

Emavusertib

Cat. No. M6258

All AbMole products are for research use only, cannot be used for human consumption.

Emavusertib Structure
Synonym:

CA-4948; CA4948; IRAK4-IN-7

Size Price Availability Quantity
Free Sample (0.1-0.5 mg)  USD 0 In stock
2mg USD 50  USD50 In stock
5mg USD 90  USD90 In stock
10mg USD 145  USD145 In stock
25mg USD 265  USD265 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Emavusertib (CA-4948) is a selective, potent and orally active inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4) that regulates IRAK4 function in the TLR and IL-1R signaling cascades.

In vitro, Emavusertib (CA-4948) blocked downstream NF-κB pathway signaling, including secretion of proinflammatory cytokines, in Toll-like receptor stimulated THP1 leukemic cells.

In vivo: Emavusertib (CA-4948) exhibits favorable DMPK properties, oral bioavailability, and is well tolerated in mice. Furthermore, IRAK4-IN-7 was previously shown to exhibit dose-dependent efficacy in ABC-DLBCL MYD88-L265P xenograft tumor models using cell lines OCI-LY3 and OCI-Ly10 and patient-derived tumors. Drug treatment led to decreased viability of MDS/AML stem cells (CD34+/CD38-/Lin-ve) in vivo studies using a THP1 leukemia xenograft model in NSG mice.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models SCID Beige mice
Formulation
Dosages 50 mg/kg
Administration p.o.
Chemical Information
Molecular Weight 417.42
Formula C21H19N7O3
CAS Number 1801343-74-7
Solubility (25°C) DMSO ≥ 10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Robert Booher, et al. Translational Sciences 1534 Combination of IRAK4 Inhibitor CA-4948 with BCL2 Inhibitor Venetoclax Induces Tumor Regression in an ABC-DLBCL Xenograft Model

Related IRAK Products
HS-243 

HS-243 is a potent and selective IRAK-4 and IRAK-1 inhibitor, with IC50 values of 20 and 24 nM.

BIO-7488

BIO-7488 is a potent, selective, oral active and CNS-penetrant IRAK4 inhibitor, with IC50 values of 0.6 nM and >30 μM for IRAK4 and hERG, respectively.

IRAK4-IN-22

IRAK4-IN-22 is an orally potent and selective potent IRAK4 inhibitor with IC50 values of 3 and 17 nM for IRAK4 and TAK1, respectively.In addition, IRAK4-IN-21 potently inhibits the production of IL-23 (IC50=0.10 µM), which may be useful in studies related to autoimmune diseases such as plaque psoriasis and psoriasis vulgaris. arthritis).

HS271

HS271 is an orally potent and selective IRAK4 inhibitor with an IC50 value of 7.2 μM. In addition, HS271 has superior in vitro enzymatic and cellular activities.

PROTAC IRAK4 degrader-3

PROTAC IRAK4 degrader-3 is a von Hippel-Lindau based IRAK4 degrader PROTAC.

  Catalog
Abmole Inhibitor Catalog




Keywords: Emavusertib, CA-4948; CA4948; IRAK4-IN-7 supplier, IRAK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.